PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision
2 other identifiers
interventional
90
1 country
1
Brief Summary
After enrollment, participants will be randomized to either receive the intervention (treatment) from trained health educators or undergo observation as usual (control group). Randomization will be stratified by HIV serostatus. A control group is appropriate because participants will still receive services offered through probation and will be offered the intervention after completion of the trial. Subjects will be paid, not for participating in the intervention, but for providing research assessments. The newly adapted intervention will be delivered over no more than a 3-month period (it will be shorter if the adaptation process is supportive). Baseline assessments will assess the pre-intervention period. The 3-month assessment will be the end-of-intervention effects and the post-intervention assessments will be at 6, 9 and 12 months. HIV prevention knowledge will be assessed based on quizzes used previously for HHRP+; though final quiz content will depend on final selected materials for the intervention. Subjects will be followed for 12 months with assessments by trained research assistants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Mar 2015
Typical duration for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2015
CompletedFirst Submitted
Initial submission to the registry
May 24, 2017
CompletedFirst Posted
Study publicly available on registry
June 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2017
CompletedAugust 4, 2021
August 1, 2021
2.7 years
May 24, 2017
August 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in HIV knowledge from baseline
HIV knowledge quiz with scores ranging from 0-100, a higher score indicating better knowledge
3 months
Secondary Outcomes (2)
Change in Sex-related risk behaviors over time
baseline, 6 months, 12 months
Change in Injection-related risk behaviors over time
baseline, 6 months, 12 months
Study Arms (2)
Holistic Health Recovery Program for HIV+ Intervention
EXPERIMENTALControl
NO INTERVENTIONInterventions
Holistic Health Recovery Program for HIV+ (HHRP+) is a CDC-recommended, evidence based behavioral (psychoeducational) group intervention focused on harm reduction principles. The investigators systematically adapted HHRP+ using findings from qualitative interviews with the target population of adult women living with and at-risk for HIV who are justice-involved (on probation, parole, or recently released from prison or jail).
Eligibility Criteria
You may qualify if:
- age ≥18 years old
- female
- have laboratory confirmed HIV OR are at-risk for HIV (ever injected drugs, ever engaged in commercial sex work, were incarcerated in prison or jail within the past 2 years, had condomless sex with an HIV+ partner or partner whose HIV status is unknown in the past 90 days, or had a diagnosed sexually transmitted infection in the past 90 days),
- and are under or anticipating transfer to probation.are either a) sentenced to probation or on intensive pretrial supervision by a probation officer; b) sentenced to parole; or c) incarcerated in jail or prison in the prior 60 days.
- Potential participants will be excluded
You may not qualify if:
- unable or unwilling to provide informed consent,
- have \<3 months of remaining scheduled supervision term,
- or are threatening to staff
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Yale AIDS Program
New Haven, Connecticut, 06106, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaimie Meyer, M.D., M.S.
Yale University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2017
First Posted
June 5, 2017
Study Start
March 3, 2015
Primary Completion
November 10, 2017
Study Completion
November 10, 2017
Last Updated
August 4, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share